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                                          Abstract 
 
Introduction: Non Tuberculous Mycobacteria commonly known as Atypical 
Mycobacteria are seen in the environment and have been isolated worldwide. The 
prevalence of NTM infections are increasing and the diagnosis is often difficult or 
unconvincing  . Identification of isolates to the species level is important, as 
infections with different Mycobacterium species often require different 
management and pathogens must be distinguished from environmental NTM 
contaminants 
 
Aim  To isolate and characterize different species of Non tuberculous 
Mycobacteria from various clinical specimens  
 
Materials and methods: The study was conducted in patients of PSG hospitals 
with clinical suspicion of tuberculosis during the period of January 2013 –July 
2014.Sputum,tracheal aspirate ,BAL, pus and tissue were obtained as specimens. 
NTMs were isolated and speciated by using conventional biochemical 
tests.Immunochromatography (TBcID test) test was used to differentiate NTM 
from M.tuberculosis. Comparative evaluation of a commercial niacin strip test 
kit(BBLTM TaxoTM TB NiacinTest Strips) with conventional niacin test was 
done. 
 
Results: A total of 3050 samples were received and processed in 
Mycobacteriology laboratory during the study period. Incidence of NTM during 
the study period was found to be 1.3%. Out of 363 culture positive acid fast bacilli, 
40(11.01%) were found to be Non tuberculous Mycobacteria. Among them 67.5%  
and 32.5% were rapid growers and slow growers respectively. The most common 
NTM isolated was Mycobacterium fortuitum( 27 %).  
 
Conclusion: The incidence of Non Tuberculous Mycobacteria was found to be 
1.3%. The commercial niacin test kit and TBc ID test were found to be 100 % 
sensitive and specific and can be used as an alternative for rapid diagnosis of 
NTM.    
 
Key words: NTM, TBcID test Commercial niacin strip test 
 
 
   
 
 
 
 
 
8                                             INTRODUCTION
9Mycobacterium belongs to the genus Actinobacteria and family Mycobactericeae. 
Mycobacteria can be classified into major groups :M.tuberculosis complex, 
M.leprae and Non Tuberculous Mycobacteria(NTM)
        Non Tuberculous Mycobacteria commonly known as Atypical Mycobacteria 
are seen in the environment and have been isolated worldwide .Other synonyms 
are MOTT (Mycobacterium other than tubercle bacilli), anonymous (or) 
unclassified mycobacteria, tuberculoid or paratubercle bacilli .The better suited 
names are environmental or opportunistic mycobacteria as their natural habitat 
appears to be the soil or water and they cause opportunistic infections in human 
beings1. 
Non tuberculous mycobacteria have been classified into four groups by 
Runyon based on pigment production and rate of growth1.Group I ,II ,III and IV 
includes Photochromogens, scotochromogens, nonphotochromogens and rapid 
growers respectively. Nearly 125 species have been identified till date. Few 
medically important species among them are Mycobacterium avium complex, 
Mycobacterium  ulcerans ,Mycobacterium kansasi, Mycobacterium fortuitum, 
Mycobacterium chelonae and Mycobacterium marinum. Most common infection 
caused by atypical mycobacterium is pulmonary disease .Mycobacterium avium 
complex causes lymphadenopathy, pulmonary lesions or disseminated disease 
particularly in AIDS patients. Mycobacterium fortuitum and Mycobacterium 
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chelonae causes chronic abscesses in human beings. Both Mycobacterium  
fortuitum  and Mycobacterium kansasi produces lung infections resembling that of 
Mycobacterium  tuberculosis. Human - human transmission has no evidence or 
documentation but the environmental exposure is suspected to produce human 
disease.
                  Since few species produces lung disease exactly like that caused by 
Mycobacterium tuberculosis, some patients with NTM lung disease are falsely 
treated for tuberculosis who will never respond to anti tubercular treatment (ATT). 
Moreover just the isolation of NTM from a sputum sample may not indicate NTM 
lung disease, as it is an organism from the environment. In order to distinguish 
between contamination and true NTM disease the American Thoracic Society has 
established a specific diagnostic criteria .Hence when a patient is diagnosed to 
have NTM infection it is very important to correlate with clinical, radiographic and 
histological findings, and the clinician should notify the laboratory when results 
are inconsistent. Such an established and ongoing professional relationship 
between clinicians and the laboratory enables the recognition of inaccurate results 
earlier, and therefore may minimize any potential harm to the patient.
                      Non tuberculous mycobacteria also produces other infections like 
lymphadenitis, skin and soft tissue infections, bone infections , keratitis and 
disseminated diseases. The current extraordinary level of interest in NTM disease 
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is the result of two different reasons, they are its and more number of people with 
NTM fall in the category without diagnosis of AIDS. Another major factor 
contributing is interest and involvement in new techniques for identification of 
NTM from patient specimens2
Several biochemical and cell level identification are been in research for 
quick identification of these organisms. The advances in molecular techniques like 
16s rRNA gene sequencing (which is accepted as standard for defining new 
species) has led to the discovery of newer species.
The prevalence of NTM infections are increasing and the diagnosis is often 
difficult or unconvincing. Treating modalities is also tricky and notorious with 
long term medications and less tolerance which proves it for less eradication2.In 
India, Non tuberculous mycobacterial infections are under diagnosed and 
undertreated when compared to developed countries. Research on the Non 
tuberculous mycobacteria is also very minimal in South India. Recognition of each 
species and its sub species is important as the treatment is different for each 
species and they have to be differentiated from the environmental NTM 
contaminants3. Thus, the appropriate diagnosis and the timely treatment pattern of 
these mycobacteria for epidemiological purposes.
Hence, this study was undertaken to find out the prevalence of Atypical 
Mycobacterial infections and the species causing disease in Coimbatore.
12
                           REVIEW OF LITERATURE
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The most acknowleged mycobacteria over centuries include,Mycobacterium 
tuberculosis and Mycobacterium leprae. The other known mycobacterial species 
are seen around us as saprophytes. Their tendency to cause the disease is identified 
as early as last century3. These were all identified as atypical mycobacteria, the 
term first coined by Pinner4.They are also referred to as non tuberculous, 
anonymous, opportunistic and Mycobacteria other than tubercle bacilli 
(MOTT).Although they are referred with various names there is no universal term 
to name them, and Non tuberculous mycobacteria (NTM) seems to be more 
acceptable and has been approved by American Thoracic Society (ATS) in their 
statement5
History of NTM:
In the late 19th century is the time "tuberculosis" was described in chickens 
in 1868 where the history of Non tuberculous mycobacteria (NTM) started. But 
this organism was identified as one distinct or different from tuberculosis bacilli 
and it was later identified to be Mycobacterium avium. It was also found these 
organisms were not found to cause any the disease after injected into guinea pigs 
and therefore it was recognized varying from Mycobacterium tuberculosis and 
were considered it cannot cause any human disease. It was only in 1930s NTM 
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was found to be causing disease in humans. In 1943 was the first time it was 
identified in lung disease due to M. avium complex (MAC) in a person who had 
silicosis8
Thirty-five years ago, the Mycobacterium genus comprised only some 30 
species. By 2004, it encompassed close to nearly 95 species.9
General characteristics:
Atypical mycobacteria are classified into four main groups. They are 
Photochromogens, Non photochromogens, Scotochromogens and Rapid growers 
.Each group contains many species which are identified as separate  species by 
using  many recent and  improved techniques like polymerase chain reaction-
restriction length polymorphism analysis (PRA), high-performance liquid 
chromatography (HPLC), 16S ribosomal DNA sequencing. Nearly 125 species 
have been identified till date.
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Scientific classification:
Kingdom Bacteria
Phylum Actinobacteria
Order Actinomycetales
Suborder Corynebacterineae
Family Mycobacteriaceae
Genus Mycobacterium
Habitat
Since there were no clues of person to person transmission, the source of 
infection is identified as environment8.They were also important environmental 
opportunistic pathogens of humans, animals, poultry, and fish9, 10. The past 3 
decades evidence has predictable that the NTM were normal population of a 
variety of ecological habitat common with humans and animals, including natural 
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occurring waters, drinking water allocation systems, and soil11.Various studies in 
India also proved its presence in environment.  Study conducted from JALMA in 
2004 has established among many mycobacteria, M. avium, M. terrae and M. 
chelonae in soil and M. avium, M. kansasii, M. terrae, M. fortuitum and M. 
chelonae in water 12.
Mode of Transmission:
Since the infection is said to be acquired from the environment and there is 
no person to person transmission9, there arises a question that how it gets 
aerosolized from the environment. The mode of transmission was once reported to 
be aerosolized from sea water bubbles and hence higher incidence of atypical 
mycobacterial disease has been reported in wide spread coastal region in 
India10.Even an epidemiological study at Chennai in 1979, revealed that one of the 
cause for BCG protection against tuberculosis in coastal region of India could be 
the sensitization of these individual with atypical mycobacteria13. It was found that 
in M. abscessus, M. fortuitum, M. chelonae, M. marinum and M. ulcerans. 
Cutaneous disease may occur by entry through the skin during any abrasion or 
surgery produced wound. It was well established even before 2000that NTM can 
multiply in the lungs even if the patient is immunocompetent. Though many levels 
are identification are there for these species their pathogenic role is not clear.
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Infections caused by NTM:
In 1961, after the advent of antibiotics, diseases due to NTM are frequently 
reported in world literature. Some of the predisposing conditions which are 
important in pathogenesis of pulmonary disease due to NTM are pneumoconiosis, 
chronic obstructive pulmonary disease and healed tuberculosis10 .Initially only 2 
species or complexes have emerged as the predominant agents of disease,
Mycobacterium kansasi, Mycobacteriumaviumintracellulare and M.scrofulaceum
complex12.Since then various spectrum of infections caused by different 
mycobacterial species has been proposed in various studies. 
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Important Atypical mycobacteria associated with infections2
INFECTIONS COMMON NTM 
ASSOCIATED
UNCOMMON NTM
PULMONARY 
DISEASE
M.aviumcomplex,M.abscesses
M.kansasi,M.malmoense
M.chelonae,M.fortuitum
M.scrofulaceum,M.celatum
LYMPHADENITIS M.avium complex
M.Malmoense,M.scrofulaceum
M.genavense
M.hemophilium
SKIN , SOFT 
TISSUE  & BONE 
DISEASES
M.chelonae,M.fortuitum
M.ulcerans,M.abscesses
M.avium complex
M.hemophilium
DISSEMINATED 
DISEASE
M.avium complex, 
M.chelonae,M.hemophilium,
M.kansasi
M.malmoense
M.conspicuum,
M.fortuitum
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Pathogenesis:
There are three important observations to describe the pathogenesis behind 
NTM infections2 Firstly in patients with HIV, NTM infection disseminated 
typically only when the CD4 T-lymphocyte count had fallen below 50/l, showing 
that specific T-cell response were required for mycobacterial resistance .Secondly, 
in Non- HIV patient group, specific mutations in interferon (IFN)-  and 
interleukin (IL)-12 synthesis and response pathways had association with genetic 
syndromes of disseminated NTM infections. Thirdly, there is also an association 
between bronchiectasis, nodular pulmonary NTM infections and a particular body 
habitus, predominantly in postmenopausal women (e.g., pectus excavatum, 
scoliosis, mitral valve prolapse)
Importance of different species of Non Tuberculous Mycobacteria:
Mycobacterium avium complex, Mycobacterium fortuitum and 
Mycobacterium kansasi were the most frequently reported potentially pathogenic 
species from various studies13.
Mycobacterium avium complex:
Two mycobacterial species namely Mycobacterium avium is responsible for 
disseminated disease and Mycobacterium intracellulare is commonly a respiratory 
pathogen together constitute Mycobacterium avium intracellulare complex 2.It has 
been commonly found to multiply in all sources of water, hot tubs and  indoor 
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water systems. They have been reported to be the cause for various pulmonary 
infections ,lymphadenitis ,bone and joint infections and disseminated infections in
Immunocompromised patients15.MAC lung disease  presents as 2 forms :apical 
fibrocavitory lung disease in males belonging to 40-50years age group and who 
have smoking and excessive alcohol use16.The other form is the one with nodular 
and interstitial infiltrates seen in nonsmoking postmenopausal females and this 
form is labeled as “Lady Windermere syndrome”17
Mycobacterium kansasi:
For M.kansasi causing human disease tap water is the major reservoir 
18.Various DNA based studies suggests that M.kansasi has many subtypes and that 
subtype I is the predominant one responsible for human infection19.Risk factors for 
M.kansasi infection includes COPD ,pneumoconiosis, previous mycobacterial 
disease and alcoholism20.They are known to cause pulmonary infections, bone and 
joint infection and disseminated infection in HIV patients7. M.kansasi is the next 
commonest organism to produce the disease in immunocompromised.21.They have 
the similar symptoms as seen with tuberculosis and the symptoms are also identical 
to pulmonary tuberculosis in case of M.kansasiinfection2 Moreover  they show 
more resistance to antitubercular drugs than Mycobacterium tuberculosis7.
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Mycobacterium fortuitum:
M.fortuitum –M.chelonae complex are rapidly growing organisms that most 
commonly involved in the infections involving soft tissues abscesses and injection 
site reactions and isolation from soil in different countries including India is 
frequent7,15.DaCosta Cruz characterized the first strain of M. fortuitum following 
its recovery from the site of vitamin injection22. Literature reports of injection 
abscess due to NTM such as M. fortuitum, M. chelonae, and M. 
abscessus following the injection of vitamin preparation, DPT vaccine, iron 
dextran and penicillin have been documented23. An Indian case report from 
Bangalore has mentioned about injection abscess due to M.fortuitumin a 3 year old 
child24.They are also known to cause joints , bursae and pulmonary infections and 
disseminated disease7. The most frequently reported etiological agent in NTM 
infection in patients wearing contact lenses or following a eye surgery like LASIK
is M.chelonae25.
M.fortuitum complex includes M. fortuitum, M. peregrinum, M. houstonense,M. 
boenickei, M. mageritense andM. Senegalense and separation of these species 
could be done only by molecular methods.These were also identified as sources of 
furunculosis  as seen with M.fortuitum and rapid growers26.
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Mycobacterium abscessus:
Mycobacterium abscessus is seen to multiply in the respiratory tract and 
produce certain pulmonary conditions in high risk groups like prior pulmonary 
mycobacterial infection, particularly tuberculosis and in white people of female sex 
with age group more than sixty years of age and those with diagnosis of cystic 
fibrosis 27,28.Mycobacterium abscessus can produce biofilms in the drinking 
distilled water.This also produces skin related infections which might resolve 
spontaneously or only after either medical or surgical treatment27,28. A study in 
United states found that major endemic area for M.abscesses disease were the 
southeastern part from Florida to Texas13. It causes cutaneous disease usually 
followed by accidental trauma or surgery in a various clinical situation 29.In India, 
a case of bacteremia secondary to a nonhealing sternal wound due to M. abscessus
following a CABG bypass graft procedure was reported in Haryana30.A fatal case 
of native valve endocarditis in a hemodialysis patientdue to Mycobacterium 
abscessus was reported in Kuwait31
M.marinum:
It is pigmented slow growing organism causes swimming pool granuloma or 
fish tank granuloma. This mycobacteria is present commonly in all water related 
sources both fresh and salt water and mostly in the stagnated wated area like fish 
tanks, swimming pools which are not chlorinated32.A case report revealed growth 
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of M.marinum seen in multiple non-inflammatory nodules with necrotic centers
and erythema on the forearm of a 29 year old immunocompetent female with 
history of rose thorn prick from Thrissur,India33.
Mycobacterium hemophilum:
It is a fastidious organism and it is slow growing in a enriched medium in 
the presence of haemin,ferric ammonium citrate or chololate agar for it to grow.
Growth is seen good in the temperatures below thirty degrees celcius7.In AIDS and 
patients after bone marrow transplantation it is found to produce life threatening 
infections34. The second risk group category consists of immunocompetent 
children in whom disease are caused which is clinically similar to that induced by 
infection with M.avium complex,M.tuberculosis,and M.scrofulaceum in whom
M. haemophilum infection induces cervical and perihilar lymphadenitis35
Mycobacterium smegmatis :
It rarely cause significant infection, has been associated with infections of 
the bone like osteomyelitis, infections of the lymphnodes, infection of the surgical 
site in the sternum after cardiac surgery, infection of the catheter site, and 
infections of the breast like abscess formation or following mammoplasty36.
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Mycobacterium scrofulaceum:
It is commonly present in atmosphere in soil, and water, household dust and 
also seen as opportunistic infection with disseminated infections, childhood 
lymphadenitis, lung disorders, and cutaneous infections38. It was known to cause 
“scrofula” (cervical lymphadenitis) in children but during early 1980s and it was 
replaced by Mycobacterium avium complex2.some studies shows that they account 
to nearly two percent of all the mycobacterial infections seen in AIDS 
individuals38.
Mycobacterium terrae complex:
It comprises of multiple species including M. triviale, M. terrae, M. 
nonchromogenicum, and M. hibernia39.Most of the isolates were previously 
presumed to be non pathogenic40 but now they are proved to cause tenosynovitis of 
hand and cavitory pulmonary disease41.M. terrae complex was also reported in 
individuals with recurrent urinary infections42.
Mycobacterium ulcerans:
It is considered as third common mycobacterium following tuberculosis and 
Lepra, in immunocompetant individuals43. The skin lesions caused by them are 
indolent, progressive necrotic and with scalloped edges known as “buruli 
ulcers”37,44. Infections are acquired through abrasion of the skin or compromised 
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skin which comes in contact with the water sources or contaminated soil . They are 
seen mostly in young kids and adults resulting with scars and deformities in the 
extremities37.
Mycobacterium xenopi:
This organism requires thermophile condition with temperature of minimum 
45 degrees celcius .They capable of colonising hot water tanks of disinfecting 
machine resulting in pseudoepidemic infection by them due to contamination of 
surgical instruments45.
Diagnosis of NTM
Speciation of NTM is more significant as a result of the variations in 
antibiotic susceptibility that determine treatment options46.All NTM isolates not 
necessarily got to be extensively identified as they might be a contaminant too. 
Therefore, communication needs to be present between clinician and 
laboratorian that becomes important in diagnosis of NTM. The clinical 
significance of NTM isolates is influenced by many factors like, the recovery from 
multiple specimens, recovery of the organism in large quantities, or recovery 
of an NTM isolate from a normally sterile site likeblood2.
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Specimen collection
The statement issued by American Thoracic Society (ATS) and Infectious 
Disease Society of America (IDSA) on diagnosis and treatment of infections 
caused by NTM emphasizes that evaluation of patients suspected of having 
pulmonary NTM infection should include the following:”Chest radiograph; chest 
high resolution computed tomography (HRCT) scan if cavitation is absent on 
radiography; three or more sputum specimens for acid fast bacilli (AFB) analysis 
and exclusion of other disorders such as tuberculosis”2. Specimen collection 
should be done by avoiding potential sources of contamination, e.g. tap water in 
which environmental mycobacteria are most commonly present. Specimens
must be collected in a container which is sterile, leak 
proof, appropriately labeled .Usually transport media and preservatives are 
not recommended. Refrigeration of specimens at 4 °C could be done just in case 
transportation is delayed by more than an hour.
Body fluid or abscess pus should ideally be collected by needle aspiration or 
surgical procedures. Sample collection should not be done using swabs as they 
often have very limited culture material and can also get dried leading decreased 
chances of isolating the NTM. The most sensitive ways of diagnosing infections 
due to NTM were found to be culture and histopathological examination of tissue 
biopsies. Care should be taken that tissue biopsy specimens are not wrapped in 
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gauze or diluted in liquid material. Tissue must be immersed in a small amount of 
sterile normal saline (not formalin) to avoid excessive drying in case if scanty 
tissue was available. Antibiotics like macrolides and quinolones ought 
to be restricted when RGM diseases are suspected as these can decrease the yield 
of RGM2.
Digestion and decontamination
When specimens are collected from non sterile areas, it is mandatory to 
perform digestion and decontamination procedures. The most commonly used 
method is the N-acetyl l-cysteine sodium hydroxide technique. NTMs are more 
vulnerable to decontamination than M.tuberculosis and hence the procedure should 
much more softer than that for M.tuberculosis2.
Smear microscopy
Acid-fast microscopy is the quickest, easiest, and least costly tool for 
the rapid identification of patients with mycobacterial infections. Though the 
specificity of acid-fast microscopy is excellent (all mycobacterial species are acid-
fast), the sensitivity isn't optimal, and this technique is unable to 
distinguish among the mycobacterium genus. The sensitivity of microscopy is 
influenced by various factors like the prevalence and severity of tuberculosis or 
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NTM disease, the type of specimen, the standard of specimen collection, the 
number of mycobacteria, present within the specimen, the 
strategy of processing (direct or concentrated), the method of centrifugation, and 
most significantly, by the staining technique and also the quality of the 
examination. Therefore, the overall sensitivity of microscopy is just between 22 –
65%47.It is recommended that a negative result should be reported solely following 
the examination of a minimum of three hundred microscopic oil 
immersion view fields (or equivalent fluorescent view fields). Therefore,
when microscopy is performed properly, it is time consuming and laborious. 
With large specimen loads, fatigue could result in the reporting of a false-negative 
result, further decreasing the sensitivity of the assay. To facilitate proper patient 
management, all results should be reported to the physician within twenty 
four hours of specimen collection or if an offsite laboratory is 
employed within twenty four hours after receipt of the specimen 47
Presently, two types of acid-fast stains are used in clinical mycobacteriology 
laboratories. One is carbolfuchsin [Ziehl-Neelsen (ZN) or Kinyoun staining 
methods], and the other a fluorochrome (usually auramine or auramine-
rhodamine). It is generally accepted that the fluorescent method should be given 
preference over the ZN and Kinyoun48.Another study done elsewhere says that the 
recommended method for staining mycobacteria is the fluorochrome method2. 
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Ziehl Neelsen or Kinyoun stain is acceptable but less sensitive. It is more prudent 
to use a weaker decolorizing agent for staining NTM as they may be more 
sensitive to the AFB decolorization procedure2.
Results of a recent survey revealed, however, that the sensitivity and 
specificity of the ZN and fluorochrome methods are comparable; whereas 
Kinyoun’s cold carbolfuchsin method was found to be inferior to both the ZN and 
fluorochrome methods 49. Moreover, fluorochrome stains may stain other bacteria 
damaged by antituberculous drugs at a higher rate than carbolfuchsin and lead to a 
false-positive result. This possibility should be considered when the specimen is 
from a patient on therapy. It is also noteworthy that, because of a tendency toward 
false-positivity with fluorochrome staining, good laboratory practice requires that 
any doubtful and smear-positive results on newly diagnosed patients should be 
confirmed by ZN or by a second examiner
In order to increase the efficacy of acid fast microscopy, a model of a 
computer-directed automated microscope was constructed 50. The automation and 
the time saving provided by this type of microscope can allow the examination of 
parallel smears from the same specimen, which could well increase the sensitivity. 
This model equipment still needs further evaluation, however, before it can be put 
into routine use
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Mycobacterial culture:
It is clear that, although acid-fast microscopy and NAA are important 
adjuncts to the detection of mycobacterial infections, they are not an adequate 
criterion alone and must be followed by growth detection. Thus, culture for the 
presence of mycobacteria is still indispensable for the following reasons: (1) 
culture is more sensitive for the detection of mycobacteria compared to acid-fast 
microscopy, (2) NTM growth pattern ,not covered by the existing NAA assays is 
needed for precise identification, (3) viable organisms are needed for the drug 
susceptibility test and (4) cultured NTM genotyping (ie, M xenopi, M chelonae, M 
malmoense, M avium, M abscessus, etc) can be used for epidemiologic purposes 
and to rule out laboratory errors (cross contamination) 51. 
Before culture, clinical specimens from non disinfected body sites should 
undergo prior treatment involving decontamination, homogenization, and 
concentration. This procedure will destroy more fastly growing contaminants like 
normal flora (other fungi and bacteria) but it does not affect the mycobacterial
viability 47. It is noteworthy, however, that the usefulness of the procedures is 
highly influenced by the exposure time of the reagent used in decontamination, the 
reagent toxicity, centrifugation effect, and the killing nature of heat during the 
process of centrifugation 47.There is proof that mildest decontamination methods 
such as NaOH method/ N-acetyl- L-cysteine kills the mycobacteria by 33% from a 
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clinical specimen, whereas methods which are more overzealous can destroy up to 
70% 47. In addition, particular patient populations might need special attention 
regarding the homogenization and decontamination method to be used. This is 
especially true for respiratory specimens from patients with cystic fibrosis because 
it has been reported that NTM are being recovered from these patients with 
increasing frequency. About 80% of these specimens, however, also contain 
Pseudomonas aeruginosa, which grows over the culture medium and thus 
preventing the NTM isolation. Recently, it was demonstrated that the N-acetyl-L-
cysteine/NaOH decontamination procedure, followed by a 5% oxalic acid 
treatment, can sufficiently reduce the overgrowth by Pseudomonas aeruginosa, 
thus improving the recovery rate of clinically significant NTM 47. 
The Centers for Disease Control and Prevention (CDC) recommend the use 
of both solid and liquid media in sort to decrease the detection time and to raise the 
yield of growth detection 52. For many years, the only culture system with the 
potential to decrease turnaround time was the BACTEC 460TB system (Becton-
Dickinson Diagnostic Instrument Systems) 53. It has been shown, however, that the 
newly introduced Mycobacteria Growth Indicator Tube (MGIT; Becton-Dickinson 
Diagnostic Instrument Systems), MB Redox (Biotest AG, Dreieich, Germany), 
BACTEC 9000 MB (Becton-Dickinson Diagnostic Instrument Systems), 
MB/BacT (Bio Me´rieux, Inc, Durham, NC) and ESPII (Accumed, Inc, Westlake, 
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Ohio) systems are suitable nonradiometric and/or fully automated alternatives to 
the radiometric BACTEC 460 TB system 54. It is noteworthy that, although all the 
alternative broth based systems showed a comparable sensitivity to the BACTEC 
460 TB system, the MGIT system exhibited a significantly better recovery rate 
conserning to the M. avium complex and other NTM (86% versus 72%, and 69% 
versus 50%, respectively), and the ESPII showed a higher recovery rate regarding 
the M. avium complex (94.6% versus 75.7%) 54. However, with the exception of 
the BACTEC 460 TB and the BACTEC 9000 MB systems, direct inoculation of 
blood is not done by the novel growth detection systems. Only after lysis and
centrifugation steps, blood samples can be inoculated into these systems 54. 
Though broth-based systems reduces the detection time to 1–3 weeks, a 
usage of solid medium must be done for those strains that may not grow well in 
liquid media 54,55. It is true in case of M. haemophilum, which will grow better on 
solid media (supplemented with hemin or hemoglobin as an iron source) 56. 
Therefore, all acid-fast microscopy positive specimens, specimens from ulcerative 
skin lesions or septic joints of immune compromised patients, specimens from 
undiagnosed pulmonary lesions of bone marrow transplant recipients, and 
specimens from children with adenitis should also be inoculated either onto 
chocolate plates, or to Middlebrook 7H10 agar with hemolyzed sheep erythrocytes, 
hemin, or an X-factor strip, or to a Lowenstein-Jensen (LJ) slant with 1% ferric 
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ammonium citrate 56. It is noteworthy that   M avium subspecies paratuberculosis
also requires additional nutrients (egg yolk and the siderophoremycobactin J) in 
both liquid and solid media for optimal growth57. Other species like M genavense,
however, show a better recovery rate in liquid media especially at an acidic pH (pH 
5.5) 58. Similar to liquid media, the pH of solid media can also significantly 
influence the growth of mycobacteria. It has been shown that for slowly growing 
mycobacteria (>7 days for visible growth in subculture), based on the testing of 16 
different species, the optimal pH in LJ medium was between 5.8 and 6.5, with the 
exception of M lepraemurium(pH 5.8–6.1) 59. As for rapid growers (visible growth 
of subculture in < 7 days), the optimal pH was between 7 and 7.4, with the 
exception of M chelonae, which preferred an acidic pH 59. These findings indicate 
that the routinely applied LJ medium with pH 7 is not optimal for the isolation of 
all mycobacteria. Therefore, in areas endemic for lung or other diseases caused by 
NTM, inoculation to an additional LJ slant with an acidic pH, or to Ogawa medium 
(pH 6), is recommended 59. 
Another benefit on solid media for culturing mycobacteria is that colony 
morphology , growth can be quantified, and pigmentation can be tested , and for 
performing  biochemical tests if needed. Other information also provides clues to 
find NTM or to guide the selection of other confirmatory tests such as DNA 
hybridization assays 60.
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Use of species-specific probes on AFB-positive sputum smears
Because the stains which are acid-fast cannot distinguish between NTM and 
M tuberculosis (MTB) complex organisms, Biological approach using fluorescence 
in situ hybridization (FISH) appears to be beneficial . Probes containing two 
peptide nucleic acid targets the 16S rRNA and was introduced to identify the NTM 
in general and MTB complex specifically in positive broth cultures 61.The FISH 
assay could be an asset in the peripheral laboratory’s armamentarium when serving 
communities with a substantial fraction of NTM diseases since no equipment 
amplification is needed. Even though the procedure can instantly differentiate 
between NTM and MTB complex, it is capable to detect the specific NTM present. 
In addition, due to a single mismatch between the 16S rRNA sequence of this 
species and that of the MTB-specific probe , it can give a weak false-positive 
signal with M marinum 61. Another drawback of the method is that the relatively 
commonly isolated species, M.fortuitum, M.flavescens, and M xenopi are not 
detected by NTM-specific probe 61. All of these species have more than one 
mismatch in the capture region of the NTM probe.
Direct nucleic acid amplification assays 
Molecular tests such as direct nucleic acid amplification (NAA) assay is 
directly used on the clinical samples in individuals who are in suspision to have 
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mycobacterial disease 62. Nowadays, the only viable test that offer possibility to 
detect a NTM (M avium) along with MTB directly from clinical specimens and 
from the same amplification reaction are the Amplicor PCR assay (Roche 
Molecular Systems, Branchburg, NJ) and BDProbeTec (Becton- Dickinson 
Diagnostic Systems, Sparks, MD) strand displacement amplification technology 63. 
But neither of these tests are approved yet for this testing aspect by the Food and 
Drug Administration in the United States. Recently, to improve the Amplicon 
polymerase chain reaction (PCR) assay and to detect the presence of a wide range 
of NTM, a Mycobacterium genus-specific capture probe was developed that can be 
used in conjunction with the pan-genus primers (targeting the 16S rRNA gene) and 
the MTB- and M avium-specific capture probes of the kit 63. This genus-specific 
screening probe was tested with both respiratory and nonrespiratory specimens 
showing an initial sensitivity of 78.5% and a specificity of 93.5%. One limitation 
of this genus-specific probe is that it can mount a ‘‘false-positive’’ outcome in the 
existence of nonsignificant NTM clinically in the specimen. To circumvent this 
problem, a second screening probe detects only the common potentially pathogenic 
(MTB complex, M avium, M intracellulare, M kansasii, M xenopi, M malmoense, 
M leprae) mycobacteria but not the clinically less significant ones 64. The initial 
sensitivity and specificity of this screening probe were 89% and 93.9%, 
respectively64. Specimen’s positive with either of these screening probes can be 
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further evaluated by hybridizing the amplicons to species-specific probes. These 
tests are done in as few as 6– 8 hours on specimens which are processed, would 
allow same-day reporting of outcome.
Identification of isolates by phenotypic characteristics:
Growth rates of colony, colony pigmentation and tests such as nitrate 
reduction, urease,  arylsulphatase, tellurite reduction, niacin production, catalase 
(qualitative and quantitative),thiophen-2-carboxylic acid hydrazide (TCH) 
sensitivity, sodium chloride tolerance,tween-80 hydrolysis, growth on MacConkey 
agar, etc., are enough to make out most of clinically important mycobacteria 65,66. 
A study from South India has also given the method to differentiate NTM from M. 
tuberculosis by various biochemical tests as shown in the table67.
Speciation of NTM by simple biochemical tests
S.NO BIOCHEMICAL TESTS M.tuberculosis NTM
1 Niacin test + -
2 Growth on LJ at 25oc - +
3 68oC catalase - +
4 Growth on LJ containing PNB - +
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This approach is, yet, time consuming and will not be decisive for a lot of
isolate with variable characteristics. Thereby, analysing the lipids of mycobacteria 
by high performance liquid chromatography (HPLC) and thin layer 
chromatography (TLC) would be considered as an alternating advance. As used by 
the side of an easier software programmes for quick study, isolates as of solid/ 
liquid medium could be quickly recognized. Serotyping method via exact serotype 
for the members of Mycobacteriumaviumintracellularescrofulaceum(MAIS) 
complex been described 68. Some serotypes of M. avium have revealed it to be 
mostly related to disease in patients with Acquired immunodeficiency syndrome. 
Proteinelectropherogram and Isoenzyme schemes are for quick characterization 
and recognition of strains of M.tuberculosis and Nontuberculous mycobacteria
which may be used even in small lab settings69. Based on the dimension of 
immunological divergence in the enzyme molecule’s structure such as superoxide 
dismutase and catalase, techniques were used for recognition of mycobacteria70,71. 
Most of these techniques are in want of expertise and specific infrastructure but 
which is not hard to put up.
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Immunochromatography test
Routine methods of culture and detection of mycobacteria are very time-
consuming, captivating for about 6 to 8 weeks for the growth of organism and yet 
another a number of weeks to months for identifying biochemically. The beginning 
of methods based on liquids, on the other hand,
has reduced the times to recognition and detection. In recent times, an add up of 
assays using MPT64 antigen assays were done to distinguish Mycobacterium 
tuberculosis complex (MTBC) isolates & Nontuberculous mycobacteria by 
immunochromatography. These kits detects MPT 64 antigen present in the 
M.tuberculosis complex isolates by means of mouse monoclonal MPT 64 antibody  
MPT64 is nothing but a protein which is produced merely by MTBC and been 
useful in distinguishing MTBC from that of NTM 72,73Studies also shown that the 
M. tuberculosis protein 64  is definite for Mycobacterium tuberculosis complex, 
which include M. tuberculosis, M. bovis, M. africanum, & a few, while it is not for 
all, substrains of M. bovis BCG74,75. The MPT 64 is an antigen specific to MTBC 
produced all through the growth of bacteria, and which is an first-rate antigen for 
recognizing the MTBC74,75.Various studies have been conducted to find out the 
validity of this immunochromatography test for identifying NTM. Recent study 
done in Lucknow showed that the specificity and sensitivity of the 
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immunochromatography kit was said to be 100 & 99.1% respectively75.Many other 
studies conducted elsewhere also concludes the same.
High-performance liquid chromatography
High-performance liquid chromatography (HPLC) done on mycolic acids of 
Mycobacterium species been considered as a fast and reproducible means to make 
out a wider range of well-known or un-known species of mycobacteria either from 
culture or from sputum 76. HPLC Users Group and CDC had given the 
Standardized procedures and pattern standards76. Species identification by mycolic 
acids is done in comparing with inhouse databases. But a computer- based pattern 
recognition method and a site on the World Wide Web (http://hplc.cjb.net), 
maintain the High-performance liquid chromatography Users Group for specific 
support of the High-performance liquid chromatography detection of 
mycobacteria, also obtainable76,77. The widely used ultraviolet High-performance
liquid chromatography is not as sensitive as the fluorescent HPLC, an adaptation 
that can considerably augment HPLC’s sensitivity whereas decreasing the time & 
the cell mass is essential for mycobacterial detection. Even though it is not as 
sensitive as NAA assays, fluorescent High-performance liquid chromatography 
been used limitedly on sputum for fast direct testing. On the whole, High-
performance liquid chromatography is hasty (less than 2 hours) and consumables 
cost are economical; yet, the assay needs a committed and skilled technician 
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(because of the chromatographic patterns are to be visual interpreted), expensive 
software & instruments, proficiency on instrumentation preservation, and 
consistent growth settings together with the want for a great biomass when using 
UV-HPLC76.
Nucleic acid hybridization methods
Use of the AccuProbe (Gen-Probe Inc, San Diego, CA) which is a nucleic 
acid hybridization kits represent a quantum leap forward in the quick detection of 
the MTB complex, M avium complex, M gordonae, and M kansasii. These assays 
allowed rapid identification of these mycobacteria (within 2 hours results) as 
shortly as adequate biomass is got subsequent to growth is in culture78. Rarely 
cross-reaction is recognized in the Accu- Probe for the Mycobacterium 
tuberculosis complex with either M terrae or M celatum types 1 and 3 isolates as
the test is not done accurately as instructed in the insert of the package79. Adhering
to the appropriate hybridization temp. ( between 60˚C and 61˚C quite than 60˚C ± 
1˚C) was the mainly the parameter of significance79. Although M gordonae has not 
been associated with disease, it is one of the most commonly isolated 
mycobacterial species. Therefore, rapid identification of this organism using a 
DNA probe has facilitated patient management by ruling out involvement of 
mycobacterial pathogens.
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A recent study found, however, that not all strains of M gordonae were 
positive with this species-specific probe80. As opposed to the nonpathogenic M 
gordonae, M.kansasii is one of the major pulmonary mycobacterial pathogens. In 
the past, identification of M kansasii in the clinical laboratory has relied on growth 
characteristics, pigmentation, and selected biochemical tests. In recent years, 
identification of M kansasii has been greatly facilitated by use of the commercially 
available DNA probe (Accu Probe, Gen-Probe, Inc); however, it has been shown 
that not all subspecies of M kansasii are positive with this probe. In order to solve 
this problem and identify all variants, a new version of the M kansasii AccuProbe 
was developed and made available 82.For the reason that Deoxyribonucleic acid/ 
Ribonucleic acid probe assays will not embrace an amplification step, these are
quiet not receptive enough to be used straight on the specimens; yet, 
Deoxyribonucleic acid/ Ribonucleic acid probes would frequently able to identify 
mycobacteria in liquid cultures that are contaminated based on the degree of 
contamination83 because they said to have a specificity and sensitivity of about
100% of when 105 organisms are there 84. Unfortunately, commercial probe assays 
are not available for the majority of the NTM.
PCR and analysis of restriction fragment length polymorphism 
In 1992 developed the concept of differentiating among slowly growing 
mycobacteria by PCR and restriction fragment length polymorphism analysis 
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(PRA) using the hsp65 gene was developed 85. Similar assays targeting the 16S 
rRNA or the dna J genes were subsequently evaluated, but ultimately a method 
based on the hsp65 gene was generated for use in routine clinical practice 86. This 
procedure can be done on isolates of AFB that develop either on solid or in liquid 
media. Because of PCR amplification, the assay needs little  biomass than either 
the HPLC or AccuProbe. Originally, 33 PRA patterns of which 19 corresponded 
to a single species, and 14 were associated with 5 species were also reported 86. 
Later, scientists added 5 additional patterns (1 more species and 4 new subtypes), 
and introduced another 11 patterns (5 additional species and 6 subtypes) into this 
algorithm 87.
A modified PRA of the hsp65 gene in addition to new algorithm which 
describes 54 species, including 22 species not described previously was also 
described88. In this assay, 10% polyacrylamide gel electrophoresis (PAGE) 
seperates the restriction digests instead of agarose gel electrophoresis. They found 
that 10% PAGE analysis provided a more precise estimate of the size of the 
restriction fragments and made the detection of mycobacteria whose PRA patterns 
contained fragments shorter than 60 bp. A drawback of PRA is misidentification 
because of intraspecies genetic variability (if the PRA pattern is not distinct). 
Intraspecies variability can be used, however, as molecular epidemiologic markers 
for particular NTM if the PRA pattern is distinct. In order to overcome this 
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problem, two new diagnostic algorithms were developed based on the PRA of the 
16S-23S DNA spacer region and on the rpoB gene of mycobacteria 89. The first
method shows fourty eight species, fourty subspecies, and four subtypes, whereas 
the second procedure identified 50 species and 13 subtypes. Both methods were 
proposed as an alternative to hsp65 PRA. 
Line Probe Assay
The commercially available kit-based Inno-LiPA Mycobacteria assay also 
identifies the  mycobacteria by  pointing  towards the 16S-23S DNA spacer region 
for 90. The LiPA method is based on the solid-phase reverse hybridization of 
biotinylated PCR amplicons of the target region to oligonucleotide probes arranged 
on a membrane strip. The system as ability for  identification of the MTB complex, 
the, M avium, M avium complex, , M kansasii, M intracellulare, M xenopi, M 
gordonae, , M chelonae and M scrofulaceum from liquid and solid media. A major 
benefits of the method is the additional ability for the simultaneous indentification 
of species in mixed cultures90.
DNA sequencing 
DNA sequencing of variable genomic regions offers a more rapid and 
accurate identification of mycobacteria compared with conventional phenotypic 
methods. In addition, it is also capable of providing phylogenic information about 
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the relatedness of strains 91. DNA sequencing methods are based on the 
determination of species-specific nucleotide sequences, which for identification are 
then compared to known sequences of in-house or commercially available 
databases 92.The most routinely used and reliable method of this kind is the 
amplification and sequence analysis of hyper variable regions of the gene encoding 
16S rRNA93. Using automated sequencers, the assay can be completed and 
identification results can be reported within 1–3 days. The installation, 
maintenance and running of automated DNA sequencing on a daily basis are 
expensive and laborious tasks, however. Nevertheless, DNA sequencing has 
enabled the discovery of new NTM species that can be non- or poorly cultivable, 
potentially pathogenic, or not yet characterized 91. It has also shown that the 
Mycobacterium genus is more diverse than it was assumed on the basis of the less-
accurate conventional identification methods 94.As a note of caution, a recent study 
demonstrated that clear-cut results with the 16S rRNA gene sequencing are not the 
rule because public or commercial databases may be inaccurate or may not include 
all established species 95. One proposed solution is the Ribosomal Differentiation 
of Medical Microorganisms system (RIDOM), which is a quality-controlled 
service, freely available on the Internet for mycobacterial identification by 16S 
rRNA analysis95. Besides sequence data, RIDOM also contains additional 
information on clinical, phenotypic, and genotypic characteristics of the 
45
established and yet to be established mycobacterial strains. Alternative DNA 
sequencing methods have been described for the characterization of mycobacteria. 
These assays are based on the amplification of the rpoB, gyrB, hsp65, and 32-kDa 
protein genes or the 16S-23S rRNA gene spacer 96,97. 
DNA chip technology 
A rapidly developing technology that appears promising for clinical 
mycobacteriology laboratories involves oligonucleotide arrays or ‘‘DNA chips’’ 
where molecular biology meets computer technology 98. Reports 99, indicate that
using an array designed to determine the specific nucleotide sequence diversity in 
10 species of mycobacteria, examined 121 mycobacterial isolates using both DNA 
sequencing of the rpoB and 16S rRNA genes and analysis of the rpoB 
oligonucleotide array hybridization patterns. Species identification for each of the 
isolates was similar, irrespective of the method used. The potential of the DNA 
chip technology was also demonstrated 100. As in the previous study, the use of a 
DNA probe array was based on two sequence databases. The first served species 
identification (82 unique 16S rRNA sequence patterns from 54 species) and the 
second, detection of rifampin resistance in MTB (rpoB alleles). Seventy 
mycobacterial isolates from 27 species and 15 rifampin-resistant MTB strains were 
tested. The same hybridization conditions could be used for both genes and the 
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platform that was described can be expanded to analyze other genes 
simultaneously as well. Epidemiologic markers could also be added to the array for 
tracing transmission links between strains. With the potential to perform direct 
testing of clinical specimens for identification and drug susceptibility and 
genotyping in one step, the DNA chip method hopefully represents the near future 
of the clinical mycobacteriology laboratory. 
Genotyping 
Recent technical advances in the field of molecular biology, in conjunction 
with an increased understanding of the molecular genetics of mycobacteria, have 
provided the means to type either MTB or NTM reliably at the DNA level 101. 
Genotyping or DNA fingerprinting of NTM provides data to assess (1) strain 
relatedness, (2) the epidemiology of NTM infections and diseases, and (3) whether 
a positive culture result was caused by cross-contamination in the laboratory 91. 
Restriction fragment length polymorphism (RFLP) assays targeting the insertion 
elements IS1245, IS1311, and IS901 have been developed to type and track 
specific M aviumcomplex strains102. A standardized and computer- assisted 
protocol was also proposed for this species103. Molecular characterization methods 
for other NTM like M kansasii, M xenopi, M celatum, M chelonae, M abscessus,
and M malmoense based on DNA fingerprinting or randomly amplified 
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polymorphic DNA-PCR genotyping have also been useful tools in the recognition 
and control of laboratory contamination, nosocomial outbreaks, and pseudo-
outbreaks
Determination of sensitivity profiles
The drug susceptibility profile of NTM is usually quite different from 
M.tuberculosis. Firstly, these organisms are usually sensitive at high 
concentrations of antituberculardrugs104, so higher cut off values for deciding 
sensitivity/resistance are recommended. Secondly, rapid growing mycobacteria are 
usually resistant to rifampicin and isoniazid (INH) whereas these are sensitive to 
drugs like new generation macrolides, cephalosporins and sulphones. The media
usually recommended for the sensitivity screening of M. tuberculosis are used for 
NTM also. Other media like chocolate agar/supplemented with ferric ammonium 
salts/mycobactins etc., will be needed for the sensitivity screening of fastidious 
species. Newer techniques like BACTEC and E test have been also found to be 
quite useful for sensitivity determination of rapid as well as slow growing NTM105. 
A new technique using recombinant ofM.avium expressing beta- galactosidase to 
evaluate the activities of antimycobacterial agents inside macrophages has been 
described106
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Treatment options for NTM
NTM Species: Clinical Aspects and Treatment Guidelines as suggested by 
American thoracic society are as follows2
General Recommendations:
 Treatment recommendations for infrequently encountered NTM are made on 
the basis of only a few reported cases. With that limitation in mind, unless 
otherwise stated, the duration of therapy for most pulmonary NTM 
pathogenesis based on treatment recommendations for more frequently 
encountered species such as MAC and M. kansasii(e.g., 12 months of 
negative sputum cultures while on therapy). For disseminated disease, 
treatment duration for most NTM pathogens is the same as for disseminated
MAC infection 
 The treatment of NTM disease is generally not directly analogous to the 
treatment of TB. In vitro susceptibilities for many NTM do not correlate 
well with clinical response to antimycobacterial drugs. Recommendations 
for routine in vitro susceptibility testing of NTM isolates are limited. The 
clinician should use in vitro susceptibility data with an appreciation for its 
limitations.
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 Empiric therapy for suspected NTM lung disease is not recommended 
 There are no widely accepted criteria for choosing patients with NTM lung 
disease for resectional surgery. In general, the more difficult an NTM 
pathogen is to treat medically, the more likely surgery should be considered 
from a risk/ benefit perspective. Expert consultation is strongly encouraged
MAC Lung Disease
Recommendations:
1. The recommended initial regimen for most patients with
nodular/bronchiectatic MAC lung disease is a three-times weekly regimen 
including clarithromycin 1,000 mg or azithromycin 500 mg, ethambutol 25 
mg/kg, and rifampin600 mg administered three times per week 
2. The recommended initial regimen for fibrocavitary or 
severenodular/bronchiectatic MAC lung disease includes clarithromycin 
500–1,000 mg/day or azithromycin 250 mg/day, ethambutol 15 mg/kg/day, 
and rifampin 10 mg/kg/day (maximum, 600 mg). An initial 2 months of 
ethambutol at 25 mg/kg/day is no longer recommended . Alternative 
treatment recommendations, including the use of parenteral agents
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3. Intermittent drug therapy is not recommended for patients who have cavitary 
disease, patients who have been previously treated, or for patients who have 
moderate or severe disease 
4. The primary microbiologic goal of therapy is 12 months of negative sputum 
cultures while on therapy; therefore, sputum must be collected from patients 
for AFB examination throughout treatment 
5. Macrolides should not be used as mono therapy for MAC because of the risk 
for developing macrolide-resistant MAC isolates .
6. A macrolide with a single companion drug, ethambutol, may be adequate for 
nodular/bronchiectatic MAC disease but should not be used in patients with 
fibrocavitary disease because of the risk of emergence of macrolide 
resistance
7. Patients respond best to MAC treatment regimens the first time they are 
administered; therefore, it is very important that patients receive 
recommended multidrug therapy the first time they are treated for MAC lung 
disease .
8. Expert consultation should be sought for patients who have difficulty 
tolerating MAC treatment regimens or who do not respond to therapy .
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Surgical Treatment For MAC Lung Disease
Recommendations:
1. Surgical resection of limited (focal) disease in a patient with adequate 
cardiopulmonary reserve to withstand partial or complete lung resection can 
be successful in combination with multidrug treatment regimens for treating
MAC lung disease 
2. Surgical resection of a solitary pulmonary nodule due to MAC is considered 
curative 
3. Mycobacterial lung disease surgery should be performed in centres with 
expertise in both medical and surgical management of mycobacterial 
diseases .
M. kansasii
Recommendations:
1. Patients should receive a daily regimen including rifampin10 mg/kg/day 
(maximum, 600 mg), ethambutol 15 mg/kg/day, isoniazid 5 mg/kg/day 
(maximum, 300 mg), and pyridoxine 50 mg/day . An initial 2 months of 
ethambutolat 25 mg/kg/day is no longer recommended .
2. Treatment duration for M. kansasii lung disease should include 12 months of 
negative sputum cultures.
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3. For patients with rifampin-resistant M. kansasii disease, a three-drug 
regimen is recommended based on in vitro susceptibilities including 
clarithromycin or azithromycin,moxifloxacin, ethambutol, 
sulfamethoxazole, or streptomycin.
4. Patients undergoing therapy for M. kansasii lung disease should have close 
clinical monitoring with frequent sputum examinations for mycobacterial 
culture throughout therapy.
M. abscessus
Recommendations:
1. The only predictably curative therapy of limited (focal)M. abscessus lung 
disease is surgical resection of involved lung combined with multidrug 
chemotherapy 
2. Periodic administration of multidrug therapy, including a macrolide and one 
or more parenteral agents (amikacin,cefoxitin, or imipenem) or a  
combination of parenteral agents over several months may help control 
symptoms and progression of M. abscessus lung disease .
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                             AIM AND OBJECTIVES
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Aim:
To isolate and characterize different species of Non tuberculous Mycobacteria 
from various clinical specimens received in Mycobacteriology lab in PSG hospitals
Objective
Primary objective:
1. To estimate the incidence of Non tuberculous Mycobacterial  (NTM) 
infections  among   tuberculosis  suspects  in PSG  hospitals.
Secondary objectives
1. To speciate NTM isolated from tuberculosis suspects  in PSG  hospitals by 
phenotypic methods.
2. Comparative evaluation of commercial niacin strip test kit and conventional 
niacin test for identification of M.tuberculosis
3. Evaluation of  Immunochromatographic tests to differentiate M.tuberculosis
from NTM
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_                         MATERIALS & METHODS
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Study Population: 
In patients and out patients of PSG hospital with clinical suspicion of 
tuberculosis
Study Locale : PSG Hospitals(in and around Coimbatore)
Study period: January 2013 –July 2014
  Sample Size Estimation: n=4pq/d2
Where n is required sample size; p is expected prevalence ;q is 100-p   and d
is degree of prevalence
Sampling Method: Convenience sampling 
Inclusion Criteria:
All patients with clinical suspicion of pulmonary /extra-pulmonary 
tuberculosis.
Exclusion Criteria:  Nil
Confidentiatility :
Anonymity of patients was done while using their samples.
Type of study - Cross sectional prospective study
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FLOW CHART FOR IDENTIFICATION OF NON TUBERCULOUS MYCOBACTERIA
Specimens from TB suspect (Pulmonary/extra pulmonary)
Smear microscopy
PositiveNegative
NALC decontamination
Smear microscopy
Negative Positive
Culture
Conventional
Negative Positive (backup)
Rapid automated 
(MGIT/BACTALERT)
Negative Positive
Immunochromatographic assay
Negative Positive
Non tuberculous 
mycobacterium
Mycobacterium 
tuberculosis
Phenotypic characterization biochemical 
tests including commercial niacin strip test 
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ETHICAL CLEARANCE: 
The study was undertaken in the Diagnostic Mycobacteriology Laboratory, 
Department of Microbiology, PSG Hospitals. Institutional Human ethical clearance 
was obtained, proof of which has been attached. Confidentiality statement was 
given to the ethics department stating that patient details disclosing their identity 
would not be included in the data collection tool.
SAMPLE COLLECTION:
All samples sent for Mycobacteriology culture were collected in sterile leak 
proof containers. For all samples wide mouth, screw cap containers were used. 
Collected specimens were transported to the mycobacteriology laboratory and 
when delayed were refrigerated.
SMEAR MICROSCOPY: 
ZIEHL –NEELSEN STAINING PROCEDURE
 Slides were arranged and  placed in serial order on the leveled staining 
bridge.to another.
Carbolfuchsin stain was added. Entire surface of the slide was covered with 
filtered Carbolfuchsin solution. If the staining solution drained off, more 
stain was added to cover the entire slide.
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The slide was heated with the flame of a bunsen burner until steam arises from 
the stain. The slide was left for ten minutes.
The slide was tilted to drain off excess stain and then staining solution was 
rinsed off gentle stream of sterile distilled water. Either a beaker, flask or 
squeeze bottle was used to pour the water on to the slides. The slide was 
tilted to drain off excess water.
The smear was decolorized by covering the whole slide with an acid solution 
(25% sulphuric acid or 3% hydrochloric acid alcohol solution) and was left 
for 3 minutes.
The slide was washed with gentle stream of sterile distilled water and was 
tilted to drain off excess water.
The smear was counterstained by covering the entire surface of the slide with 
methylene blue solution and was left for 30 seconds to 1 minute.
 Slide was rinsed with gentle stream of sterile distilled water to drain off the 
methylene blue solution under side of the smear was wiped.
 Slide was placed on the slide rack to air-dry. After drying they were screened 
under microscope.
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SMEAR EXAMINATION: 
A drop of emulsion oil placed on the dried smear without touching the slide. 
The smears were examined with the 100 x oil immersion 
objective.Minimum of 100 fields were examined before the smear was 
reported as negative. Smears were graded as per RNTCP grading.
RNTCP GRADING OF SPUTUM SMEARS 
Result Grading No. of fields to be 
examined
>10 AFB/OIF Positive 3+ 20
1-10 AFB/OIF Positive 2+ 50
10-99 AFB/100 OIF Positive 1+ 100
1-9 AFB 100 OIF Positive Scanty* 100
No AFB in 100 OIF Negative 100
*Record the actual number of bacilli seen- e.g “scanty 3”
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CULTURE PROCEDURE :
All processing work was done in biosafety cabinet Class II type A2 under 
strict aseptic precautions. Illustration 1
CONVENTIONAL CULTURE 
Condensed moisture observed at the of bottom of culture medium slant were 
removed partly before inoculation. Two slopes of Lowenstein Jensen medium (LJ) 
were inoculated in case of conventional cultures. In case of MGIT/BactAlert one 
LG medium was taken as a backup. Each slope was inoculated with 0.2 to 0.4 ml 
of the centrifuged sediment, distributed over the surface. Inoculated media were 
incubated in a slanted position for at least 24 hours to ensure even distribution of 
inoculum. Tops were tightened to minimize evaporation and drying of media.
INCUBATION OF CULTURES:
All cultures were incubated at 35 – 370C until growth was observed or 
discarded as negative after 8 weeks. One slope LJ was incubated at 25-300C if the 
specimens were obtained from skin and superficial lesions.
CULTURE EXAMINATION:
Cultures were examined after 48-72 hours of inoculation to detect gross 
contaminants. If both LJ slopes were grossly contaminated (those where the 
surface has been completely contaminated or were medium had been liquefied or 
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discolored) they were discarded and sample was re-decontaminated and re-
inoculated onto two LJ.
Thereafter cultures were examined weekly up to 8 weeks. Slopes were further 
incubated for 12 weeks, in case of specimens which were smear positive but 
showed no growth at the end of 8 weeks or in case of suspected M.avium –
intracellular complex infection.
MYCOBACTERIA GROWTH INDICATOR TUBE (MGIT) CULTURE
1. The lyophilized PANTA (PolymyxinB, Azlocilin, Nalidixic-acid,
Trimethoprim and AmphotericinB) powder was reconstituted with 15 ml of 
OADC( Oleic acid, Albumin, Dextrose and catalase) supplement solution. 
Once reconstituted, it was stored at 2-80C and was used in 6 days.
2. MGIT tube was taken and with the help of marker ,inoculation date and 
sample number was written on the tube.
3. 0.8ml of PANTA OADC solution was added aseptically to the MGIT tube.
4. Then 0.5 ml of digested and decontaminated concentrated sample was added 
to MGIT tube.
5. Cap of the MGIT tube was tightened and mixed well.
6. The tubes were incubated at 370C in the incubator.
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7. The tubes were taken out on the 4th day and were read on the  BACTEC 
MICRO MGIT system.
8. First, the calibrator tube was placed in the slot and was adjusted.
9. Then the inoculated MGIT tube was placed in the slot and checked. If the 
green light was in the black zone it was negative and if it was in the red zone , 
it was considered as positive.
10. Tubes turning negative were placed back into the incubator and was read until 
they turn positive or upto 42 days.
11. Tubes turning positive were checked for turbidity or contamination by ZN 
staining and by streaking on blood agar.
MGITTMTBc IDENTIFICATION TEST:
Principle of the procedure:
The TBc ID test is a chromatographic immunoassay for the qualitative 
detection of Mycobacterium tuberculosis from an AFB smear positive MGIT tube. 
This product detects MPT64, a mycobacterial protein fraction that is secreted from 
M. tuberculosis cells during culture. When samples are added to the test device, 
MPT64 antigen binds to anti-MPT64 antibodies conjugated to visualizing particles 
on the test strip. The antigen –conjugate complex migrates across the test strip to 
the reaction area and is captured by a second specific MPT64 antibody applied to 
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the membrane. If the MPT64 antigen is present in the sample, a color reaction is 
produced by the labeled colloidal gold particles and is visualized as a 
pink to red line.
Procedure :
1.TBc ID device was removed from the foil pouch immediately before testing and 
was placed on a flat surface.
2.AFB smear positive MGIT tube was thoroughly mixed by inverting or vortexing.
Hundred µl of the sample was pipetted into the sample well of the labeled device.
3.Result was read after 15 minutes.
Interpretation of the test;
Positive test- A pink to red line appears at the Test “T” position and the 
control “C” position in the read window. This indicates MPT64 antigen was 
detected in the sample.
Negative test- No pink to red line is visible at the Test “T” position of 
the read window. This indicates MPT64 antigen was not detected in the sample.
A line at the control “C” position in the read window indicates proper 
performance of the test procedure.
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This TBcID test helps in identifying NTM from culture positive mycobacteria. 
Once NTM was identified, duplicate sample was obtained to rule out 
contamination.After confirmation of NTM infection, further characterization of 
NTM was done using various biochemical tests.
BIOCHEMICALS FOR  IDENTIFICATION : 
A.GROWTH ON LJ WITH PARANITRO BENZOIC ACID107: 
1. A loop full of culture was taken in a McCartney bottle containing 1 ml 
sterile distilled water (SDW) and 6 glass beads of diameter 3 mm.
2. Vortex was done for 20-30 sec.
3. 4 – 5 ml of sterile distilled water was added slowly with continuous 
shaking.
4. Coarse particles were allowed to settle down
5. Supernatant was decanted carefully into another sterile bottle
6. McFarland 0.5 standard was matched and a loop full was inoculated on 
LJ with PNB.
B.TESTING FOR GROWTH RATE AND PIGMENT PRODUCTION107: 
Principle of photosensitivity testing:
The appearance of yellow pigment in the colonies of photochromogenic 
mycobacteria is the result of yellowish orange carotene crystals that are produced 
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by actively metabolizing micro organisms after exposure to bright light. 
Scotochromogenic species have capability of producing yellow pigment without 
exposure to light: however the type of pigment is unknown; the pigmentation of 
young colonies of mycobacteria after growth in the dark or following exposure to 
light can be an important aid in the identification of certain mycobacterium species
 A primary broth culture of the test organism, diluted sufficiently to 
produce isolated colonies when was taken
 Materials needed were Biologic safety cabinet, 370 C incubator, sterile 
screw capped test tubes , 20 X 110 or 20 X 125 mm, sterile Pasteur 
pipette, inoculating wires and loops, three slants of Lowenstein Jensen 
medium
Procedure:
1. A suspension of growth in sterile distilled water was prepared and 
matched the turbidity to McFarland 0.5.
2. 0.1 ml of the suspension was inoculated to 3 tubes of LJ agar
3. Two LJ were wrapped with aluminum foil and the third was left exposed
4. One of the wrapped tubes was incubated at 25-30 0 C and the other tubes 
were incubated at 370 C
5. The exposed tube was examined daily for one week and then once 
weekly for growth. This gave the growth rate of the isolate.
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6. If growth was detected in the exposed tube, the wrapped tubes were 
examined for growth and pigmentation.
7. Anyone one of the wrapped tubes was exposed to a strong light for 5 
hours (100W Tungsten bulb). The cap of the culture tube was loosened 
during this period.
8. Following exposure to light, the tube was returned to the incubator and 
was inspected after 24-48 hours (72 hrs if at 300 C) for the appearance of 
yellow pigment.
NIACIN TEST108 (conventional):
Principle 
All mycobacteria species produces niacin .Mycobacterium tuberculosis gather the 
maximum quantity of niacin and its recognition is helpful for its ultimate  analysis.  
Niacin negative M. tuberculosis strains are rare, while very few other yield 
positive result.  
The following were needed for the procedure:
• Test culture on Lowenstein Jenson medium
(It should be atleast 3-4wks old with 2+ growth).
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•   Affirmative (+ve) Control: Mycobacterium tuberculosis H37Rv 
• Non affirmative (-ve) control: Condensed water from uninoculated Lowenstein 
Jenson medium                                           
• O-toluidine -1.5 percent 
• Cyanogen bromide (CNBr) 10 percent   
CNBr is  highly toxic & hazardous so, a saturated solution of CNBr which is  10%, 
was used .More distilled water is added and left overnight at four degree Celsius in 
the refrigerator.  
Procedure:
• A four weeks old Lowenstein Jenson culture was selected having atleast 2+ 
growth & includes both controls 
• Laboratory identification number was entered    
• Serial number was identified on slopes 
• Water of condensation was checked in the culture tube 
• 0. 5 or 1 millilitre of sterilized water was mixed if necessary
• Bottles are placed in autoclave at 121 degree Celsius for thirty min & cooled to 
room temperature
• 0. 25millilitre of the water of condensation was moved to a clean tube  
• 0.25 millilitre of 1. 5% O-toluidine was added.
• 0. 25 millilitre of 10 percent CNBr  was added & mixed 
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• Colour formation was observed in five min.
Interpretation:
• If colour is pink- Niacin is affirmative
• If white precipitate is formed-Niacin is non-affirmative
• Test tubes were discarded in  4% sodium hydroxide soln.
Detection of production of Niacin by strip tes using BBL™ Taxo™ TB Niacin 
Test Strips
Preparation of controls:
An positive(+ve) control with BBL Taxo TB Niacin Test Control was run 
along with all series of tests & was equipped as below:
* 0.6 millilitres of sterilized saline or deionized or distilled water is 
mixed in a 13 x 75 mm tube.
* One BBL TaxoTB Niacin Control disc was supplemented & 
shuddered slowly 3 times during fifteen minutes in room temperature.
A negative(-ve) control was made ready by mixing 0.6 mL of the same 
diluent to  13 x 75 mm  tube instead of extract.
Test Procedure:
1. Culture being tested for presence of niacin was processed and 0.6 mL  
of the extract  was placed in a 13 x 75 mm test tube .
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2. Non affirmative (-ve) for this is kept in 13 x 75 millimeter test tube & 
affirmative (+ve) control were kept ready.
3. Using flamed forceps,  aBBL TaxoTB Niacin Test Strip was dropped
arrow pointing downward into each tube & stoppered immediately.
4. Tubes are gently shuddered to mix fluid with reagent on bottom of 
strip, not tilted. Such smooth shaking was repeated after five to ten 
min.
5. After twelve to fifteen minutes, but not more than thirty min, color 
were compared
6. The above tubes were autoclaved after completing the test.
Interpretation:
Colour of extract - Yellow   - Niacin positive
Colour of extract- Nil          - Niacin negative
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ALGORITHM FOR SPECIATION OF NONPHOTOCHROMOGENS
   +                                 -
                                                 +         -
Non Photochromogen 
Growth on PNB positive
Tween hydrolysis
Nitrate 
Reduction
68 C Catalase Weak +
Nitrate reduction -
SQ Catalase  -
Urease + 
M.avium complex
SQ Catalase68 C Catalase + 
M.terraetriviale complex Urease –
M.xenopi
M.triviale( growth on 5% 
NaCL+) 
M.terrae complex ( growth 
on 5% NaCl
M. Malmoense (680C Catalase +) 
M.gastri (680C Catalase-)
M. nonchromogenicum  
(68C Catalase+)
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ALGORITHM FOR SPECIATION OF  PHOTOCHROMOGENS
                                           +         +                 -
                                                                              +     =     +                 -
                                                       +               _
Photochromogen
Pigment on exposure to light
Nitrate 
reduction
SQ catalase +
Tween hydrolysis +
680C catalase +
Urease +
SQ catalase
Tween hydrolysis +
2 week aryl sulfatase +
Tween hydrolysis
M.marinumM.simiae
M asiaticum
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ALGORITHM FOR SPECIATION OF SCOTOCHROMOGENS
                                     +                               -                    
                 +                            -  
                +     -
Scotochromogen
Tween hydrolysis
Nitrate 
reduction
SQ catalase +
68 C catalase +
Urease+
M scrofulaceum
Pigment intensified at 
220C
M gordonae
M.szulgai
SQ catalase +
68 C catalase +
Urease+
M.flavescens
SQ catalase +
68 C catalase +
Growth on 5% NaCl +
Urease +
SQ catalase +
68 C catalase +
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ALGORITHM FOR SPECIATION OF RAPID GROWERS
Rapid growers
M.fortuitum M.chelonae
Nitrate
3 day Aryl sulfatase 
test
Mycobacterium 
smegmatis
Other rapidly 
growing 
Mycobacterium 
Mycobacterium 
vaccae
Pigment 
Yellow to 
orange pigment
Buff 
Smooth 
colony
Smooth 
colony
Rough colonyRough colony
Mycobacterium 
phlei
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CATALASE TEST107:
Principle: 
Catalase breaks H2O2 into H2O and O2. The formation of O2 shows as bubbles, 
a minimal form of catalase is disactivated by boiling at 600 C for twenty min, an 
important feature for few mycobacterium sp. The  H2O2 used for the recognition of 
Mycobacterium sp. varies from H2O2 used to find catalase in other types, with use 
of 30 percent concentration (superoxol) in 10% Tween 80 solution . This helps in 
dispersing the densely clumped mycobacteria preventing it from aggregating to 
individual bacilli, increasing the identification of catalase.
 Grown up colonies of the unidentified Mycobacterium sp. Found in from 
clinical specimen , grown on Lowenstein Jenson slant or middle brook 7H-
10 agars were taken
 Materials needed were 680 C water bath;Medias – middle brook 7H9 broth, 
LJ deeps in 25 x 150 mm screw- capped test tubes; Reagents – 30% 
hydrogen peroxide , 10% Tween 80, M/15 phosphate buffer (0.067 M)
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Procedure :
(i) Heat stable catalase test 
1. With a sterile pipette 0.5 ml of 0.067M buffer was aseptically added in 16 x 
125 millimeter test tubes which are screw capped.
2. Loop full of unidentified culture was suspended in solution containing buffer 
with sterilized loop.
3. Such tubes which has emulsified culture were placed in a already boiled water 
bath to 680 C for twenty min.
4. The tubes were removed from heat and cooled to room temperature.
5. 0.5 millilitre of newly formed Tween – a mixture with peroxide was added to 
every tube
6. Development of bubbles on surface of the liquid was observed.
7. Negative tubes were holded for 20 minutes before discarding.
(ii)Semiquantitative catalase test :
1. Liquid medium such as Dubos Tween broth of Middle brook 7H9 broth was 
inoculated with a loop full of the culture to be tested.
2. Inoculum was incubated for 7 days at 370 C 
3. After incubation the inoculum was taken and mixed on  Vortex mixter for 5-10 
seconds
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4. 6 drops were transferred to LJ deep
5. LJ deeps were incubated for 14 days at 370C .the caps were left loose.
6. I ml of freshly prepared Tween 80 – hydrogen peroxide agent was added to the 
LJ deep
7. The test tubes were left for five min in room temprature
8. Total column of bubbles was measured
Interpretation :
1.Heat stable catalase test : the formation of bubble shows a affirmative test and 
absence of bubbles is non affirmative test.
2.Semiquantitative catalase test : high catalase reaction - > 45mm
                                                      Low catalase reaction - < 45mm of foam
NITRATE REDUCTION TEST 107:
Principle : 
Those Mycobacteria which produce nitro reductase are able to catalyse reduction 
of alpha nitrate to nitrite. Here, O2 is extracted from nitrate 
NO3 + 2e + 2H     NO2 + H2O
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Nitrate formed is found  by the adding napthalamine & sulpfanilic acid , which 
forms the  red diazoniumdye,Para sulfobenzene-azo alpha napthalamine.
Specimen:
-A three to four wks old culture of given unidentified organism growing on 
Lowensten Jenson medium or other coagulated egg medium.
-Materials needed were Biologic safety hood,370C water bath or heating 
block,sterile Pasteur pipettes,sterileforceps;reagents-Nitrate test substrate(0.01 M) 
in M/45 phosphate buffer(0.02 M,pH 7.0)
Procedure:
One loop of unidentified colonies from solid medium was were emulsified in two 
ml of substrate
It was mixed well and incubated in thirtyseven 0Celsius for 2 hrs.
Reagents were added in the following method to mixture
1 drop of Conc Hydrochloric acid
2 drops of 0.2 percent sulfanilamide
2 drops of 0.1 percent N-(1-naphthyl) ethylenediamide 
dihydrochloride
Solution was allowed for 5 min in room temperature.
Formation from pink to red colour was observed.
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Results: The appearance of pink or red colour was taken as  indicative of a positive 
test. If no colour change occurred, it was considered negative.lt was confirmed by 
adding a small amount of zinc dust. A deep red to pink colour after the addition of 
zinc dust indicated that nitrate was reduced by zinc. 
ARYLSULFATASE TEST107 :
Principle:
Aryl sulphatase is an enzyme that splits free phenolphthalein disulfite.This test is 
performed for identification of mycobacterium species in a tube having a substrate 
of phenolphthalein with oleic acid agar. Its incubated for three to fourteen days 
with subculture of  unidentified species, the formation of pink colour after adding 
Na2CO3  proves a affirmative test. 
Specimen: Mature colony ,unidentified mycobacterium sp. recovered  from 
clinical material ,developed on Lowenstein Jenson slant .
Procedure :
1.The substrate tube was inoculated with turbid suspension of the test 
organism and was thoroughly emulsified.
2. It was incubated for 3 days or 14 days(2 week test) at 350C in the non CO2 
incubator.
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3. After incubation,1 millilitre of 2N Na2CO3 reagent was added & mixed. 
Colour was observed.
Results:
Colour change from pale pink to deep red indicated positive reaction. Lack of 
colour change indicated negative reaction.
GROWTH ON MAC CONKEY AGAR107
Principle
The capacity to develop on special MacConkey agar, without crystal violet 
formulation, differentiates Mycobacteria fortuitum, Mycobacteria chelonae & 
Mycobacteria abscessus, which are able to grow within Five days, which differs 
from other specis as they have very slight growth even after 11 days.
Specimen :
A Mature colony of  Mycobacterium sp. recovered from specimen , grown on a LJ 
slant or on middlebrook 7H10 agar is examined
Procedure:
1. A fresh MacConkey was inoculated with 3 drops of organism grown for 
seven to ten days in 7H9 broth
2. It was incubated at  28 to 30 degrees for eleven days without carbon di oxide
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3. At Five and eleven days , absence in growth indicated a negative test and 
presence of growth indicates positive test.
TOLERANCE TO 5% SODIUM CHLORIDE107
Principle : Among slowly growing mycobacteria species, only Mycobacteria 
triviale grows well in media with 5% NaCl ;of the clinically important rapid 
growing  mycobacteria, M. chelonae subspecies .chelonei didn’t grow in this 
media.
Specimen :
An three-four week old culture of  test species growing on LJ medium or other 
coagulated egg medium.
Materials needed were biologic safety hood, slant racks, Sterile applicator sticks, 
sterile 1.0 ml Pipettes, McFarland 1 standard; medias -Lowenstein-Jensen without 
5% NaCl in slants, Lowenstein-Jensen with 5% NaCl in slants and Dubos Tween 
or Middle brook 7H9 broth
Procedure :
1.An actively growing culture (2 to 4 weeks for rapid growers)was used. A 
suspension of organisms was made in Middlebrook 7H9 broth equal to McFarland 
1 standard
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2. One Lowenstein-Jensen slant with 5% NaCl was taken and 0.1 millilitres of 
described suspension was introduced into each tube,.
3. The slants were incubated with the caps loose in a 5 to 10% CO2 incubator. The 
slants were left flat in a rack during incubation. The slants were incubated for 1 
week at 29-300C 
Results :
1. When numerous colonies were seen on the control slant and more than 50 
colonies on the medium containing 5% NaCl , test was recorded as positive.
2. When there were colonies on the control slant and no visible growth on the slant 
containing NaCl, incubation was continued for upto 4 weeks .
TWEEN HYDROLYSIS 107: 
Principle :
Tween is polyethylene derivative of sorbitan mono-oleate. To detect oleic acid is 
released from Tween 80 due to presence of enzyme.
Colour changes can be observed from orange to pink mainly because of  hydrolysis 
of Tween 80 M/15 
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Procedure
0.5 Millilitres of Tween-80 was mixed  in 100 millilitres of buffer of phosphate 
.2ml of neutral red solution was added to it.  2 ml of the reagent was poured in test 
tubes which are screw capped and sterilized at Fifteen lbs pressure for 15 min. The 
tubes were stored in cool temperature, in containers which had an amber color.
Procedure :
One loopful of culture from L-J slope was added to the substrate tube and was 
incubated at 370C
Result was read at 24 hours, 5 days and at 10-12 days
Change of colour from amber to pink or red was interpretated as positive. The day 
of observation of the positive reaction was recorded.
TESTING FOR UREASE PRODUCTION BY MYCOBACTERIA107
Procedure :
To the urea broth prepared,colony was inoculated heavily from a solid medium. It 
was incubated at 370C for 1-7 days.Development of pink colour( positive test) was 
observed.
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                                                       RESULTS
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A total of 3050 samples were received and processed in Mycobacteriology 
laboratory during the study period  January 2013 to July 2014.Among them, 
363(11.9%) were culture positive and AFB smear positive.
Incidence of NTM during the two year period was found to be 1.3%.
 Figure 1 shows the distribution of Mycobacterium species among the 
various samples received. Out of 363 culture positive acid fast bacilli, 
40(11.01%) were found to be Non tuberculous Mycobacteria and the others 
(88.99%) were found to be Mycobacterium tuberculosis complex.
 Figure 2 depicts the distribution of NTM and Mycobacterium tuberculosis
complex from clinical samples. 
 NTMs were most commonly isolated from sputum samples(85%) followed 
by broncho alveolar lavage(7%),tracheal aspirate (2%) ,pus (2%) and 
TISSUE(2%).Figure 3shows the pattern of distribution of NTM from 
various clinical samples 
 Growth on Lowenstein Jensen medium with paranitro benzoic acid (PNB) 
showed  100% positivity. Illustration 2
 All isolates of NTM (100%) showed positivity for Immunochromatographic 
test( MGITTMTBc Identification test) done with MGIT(Mycobacterium 
Growth Indicator Tube).Taking culture on LJ with PNB(Para nitro benzoic 
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acid ) as gold standard, the sensitivity, specificity, positive predictive value 
and negative predictive value were found to be 100% .
 Illustration 3 shows the  results of the  Immunochromatography test for 
detection of MPT 64 antigen which was negative for NTM.
 Table 1 depicts the results obtained from the Immunochromatographic test 
kit..
 A representative sample of 50 isolates were  tested to compare conventional 
niacin test with commercial niacin strip(BD BBLTM TaxoTM Niacin strip 
test ) method .Among them,40(80% isolates were niacin test positive and 10 
(20%)isolates were negative by both method. Commercial niacin strip test 
kit was found to be 100% sensitive and specific. Positive predictive value 
and negative predictive value was also found to be 100%.
 Table 2 depicts the results of commercial niacin strip test.
 Among the 40 NTM isolated, there were 27(67.5%) rapid growers and 
13(32.5%) slow growers. Figure 4 illustrates the distribution of rapid 
growers and slow growers among the NTMs isolated.
 Table 3 and Table 4 show the distribution of rapid growers and slow 
growers respectively
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 Table 5 shows the speciation of NTM species isolated by various 
biochemical tests.
 Illustrations 4-9 show various biochemical tests done to characterize NTM.
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Figure 1-Distribution of Mycobacterium among total samples received in 
Mycobacteriology laboratory
Figure 2- Pattern of NTM among the Mycobacterium species isolated
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Figure 3-Distribution of NTM among various samples
Figure 4 :Distribution of Rapid growers and slow growers
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Table1:  Results of  Immunochromatography test - TBc ID test
TBcID 
test
Growth on PNB
Positive                         Negative         Total
Positive 40               0 40
Negative 0 0 0
Total 40 0 40
Sensitivity -100%
Specificity - 100%
Positive PredictiveValue -100%
Negative Predictive Value - 100%
91
Table 2 : Comparative evaluation of Niacin (conventional) and Commercial
Niacin strip test
Commercial 
niacin strip 
test
Conventional niacin test
Positive                         Negative                
Total           
Positive 40 0 40
Negative 0 10 10
Total 40 10 50
Sensitivity =100%
Specificity = 100%
Positive Predictive Value =100%
Negative Predictive Value= 100%
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Table 3 : Distribution of rapid growers
                                                                                      n =27
S.No Rapid growers Number 
1 Mycobacterium fortuitum 11(40.7%)
2 Mycobacterium smegmatis 10(37.03%
3 Mycobacterium chelonae 4(8.5%)
4 Mycobacterium vaccae 2(7.4%)
Total 27
Table 4: Distribution of slow growers
n = 13
S no Slow growers Number
1.
Non Photochromogens
Mycobacterium avium complex 4(30.7%)
2. Mycobacterium terrae complex 4(30.7%)
3. Mycobacterium xenopi 3(23.07)
4. Mycobacterium nonchromogenicum 1(7.6%
5.
Photochromogen
Mycobacterium kansasi 1(7.6%)
Total 13
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Table 7: Speciation of Non tuberculous Mycobacteria
                                                                                                                               
                                                                                                                   n=40
Growth 
characteristics
Rapid 
growers(27)
Positive  Negative      
Non 
photochromogen(12)
Positive   Negative 
Photochromogen
(1)
Positive   Negative
Nitrate reduction 
test
17              10 7                  5 1                  0
680C catalase test 27               0 12                   0 1                   0
3 day aryl sulfatase 
test
15              12 NA               NA NA          NA
Tween hydrolysis 
test
NA             NA 5                     7 1                    0
Growth on 
McConkey agar
11             16 NA              NA NA           NA
Sq catalase NA           NA 5                      7 1                 0
Urease test NA            NA 6                      6 1                 0
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Illustration 1:Biosafety cabinet class II A2
Illustration 2:Growth on LJ with PNB
                                          Negative                        Positive 
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Illustration 3:TBc ID test (MGIT TMTBcID )
                    Negative (NTM)               Positive (M.tuberculosis complex)
Illustration 4:(a)Niacin test-conventional
                                                           Negative test     Positive test
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(b)Niacin commercial strip test
                                      Test positive         +ve Control        -ve control            test negative
Illustration 5:Nitrate reduction test
Positive        Negative  
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Illustration 6:Tween hydrolysis test
                                                 Negative     positive 
Illustration 7:Growth on McConkey agar
                          Positive    Negative
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Illustration 8:Semi Quantitaive Catalase test
Illustration 9:Growth on 5% NaCl
                 Negative Positive
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                                                  DISCUSSION
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Non Tuberculous Mycobacteria has developed into a significant pathogen since 
AIDS era. Infections are most commonly seen in immune compromised patients 
and people with respiratory illnesses. In countries like India, where tuberculosis is 
endemic, there is an under reporting due to various reasons and it continues to be 
one of the threats for development of multidrug resistance in India. Recent 
awareness in the spread of infection and the advances in the laboratory diagnosis 
have made improvement in identification of NTM infections.
In our study, the incidence of NTM was found to be 1.3% among the 
tuberculosis suspects in our hospital. This is higher when compared with a study 
conducted in North India  which showed prevalence of 0.38%109.A study from 
Chennai, South India has reported 8.6% of NTM from sputum specimens of 
patients in BCG trial area110.Another study conducted in Canada showed very high 
prevalence of 41.3% 111.This could  be due to actual surge in prevalence of the 
disease or due to availability of better diagnostic procedures, whereas the lesser 
prevalence in our country could possibly be due to under diagnosis of NTM 
infections.
Most of the NTMs were isolated from respiratory samples (95%).A study 
from North India has reported NTM isolation from respiratory samples to be 
45%109.
101
Among the isolated NTMs, 67.5% were rapid growers and 32.5% were slow 
growers .These results correlate well with a study done in South India showed that 
rapid growers accounted for 67% of the NTM isolated112. The common NTM 
species reported by developed countries were M.avium and M.kansasi113.In 
contrast to them, in the present study M.fortuitum (27.5%) was found to be the 
commonest NTM species. A study conducted elsewhere also has reported 
M.fortuitum(47%) to be the commonest species114.
PNB positivity was 100% in the present study. Another NTM study 
conducted  in North India also showed 99% PNB positivity115. A study from South 
India has stated that Growth on LJ with PNB, niacin test, nitrate reduction were the 
tests used to differentiate NTM from M.tuberculosis complex67.
Immunochomatography test with TBcID test kit (BD) revealed 100% 
sensitivity and specificity. This was comparable with another study done in North 
India where sensitivity and specificity of Immunochomatography test were 99.1% 
and 100 % respectively116.This simple test could be used as an aid to differentiate 
M.tuberculosis from NTM from liquid cultures
Commercial niacin strip test for differentiation of Mycobacteria was found 
to be 100 % sensitive and specific when compared to conventional method. Similar 
results were shown in a study conducted in Delhi that the commercial strip test 
gives comparable results with conventional tests117.Hence the commercial test 
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strips could be a good alternative to the laborious conventional method. Moreover, 
it also has the advantage of avoiding the hazardous exposure of cyanogen bromide 
which is used in the conventional niacin test. 
Treatment options differ once the patient is diagnosed to have NTM 
infections and species it is recommended that macrolides could be prescribed.
        The data collected from the case records of 40 patients, showed that in five 
cases, the treatment protocol was changed for NTM. All these patients were treated 
with amikacin, levofloxacin and macrolide (either azithromycin or clarithromycin) 
combinations. They were found to have responded well to the NTM regimen on 
follow up. Most of the patients were treated for tuberculosis with first line anti-
tubercular drugs and as they were responding well, they were continued on Anti 
Tuberculous treatment. This could be due to certain drugs like Rifampicin and 
Ethambutol, which are active against certain NTMs.
The report of acid fast bacilli in smears mandates the start of treatment for 
tuberculosis by physicians as per the RNTCP. Due to the slow growth of the 
bacteria culture is delayed and phenotypic methods though available are 
cumbersome to perform in resource limited settings. Rapid methods like Gene 
Xpert has revolutionised the detection of MDR tuberculosis. Genotypic methods 
like Line probe assay, restriction fragment length polymorphism 
analysis(PRA),gene sequencing etc are available for NTM and are found to be 
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good alternatives for the early detection and rapid diagnosis which will aid 
physicians to institute treatment for patients.
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                                                   CONCLUSION
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1. The incidence of Non Tuberculous Mycobacteria was found to be 1.3%
2. The distribution of rapid growers and slow growers were 67.5% and 32.5% 
respectively.
3. The most common NTM isolated was Mycobacterium Fortuitum( 27 %)
4. Growth on LJ with PNB  was found to be 100%
5. The TBcID immunochromatography test kit showed 100 % sensitivity and  
specificity.
6. The commercial niacin strip test kit was found to be 100 % sensitive and 
specific when compared with conventional niacin test.
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Annexure I – Ethics clearance form
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Annexure II – Data Collection Tool
Sample no:                            Age:                                              Sex: M/F
Ward /OP:                   
Brief clinical history:
New case/Old case:
Date of collection:
Specimen:                                                                If sputum: Spot/morning
Smear report:
  Date of                                                                     RNTCP
reporting                            Report                           grading   
                         25% ZiehlNeelsen
                         Direct smear         :        
                         Concentrated smear:
                         Any other specify:     
Primary culture:
Date of inoculation                        Method               Expected date of final report    
                                                   Conventional
                                                   Automated
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Annexure III – Media and Reagents
1. LOWENSTEIN AND JENSEN MEDIUM:
Mineral salt solution
Potassium dihydrogen phosphate                        2.4grams
Magnesium sulphate                                             0.24grams
Asparagine                                                              3.6grams
Magnesium citrate                                                 0.6grams
Glycerol                                                                     12ml
Distilled water                                                          600ml
Malachite green solution  (2%)                              1000.0ml
The ingredients of mineral salt solution were dissolved by heating.It was 
sterilized by autoclave at 121ͦC for 20 minutes and then stored at 4ͦC
A 2% solution of malachite green was prepared in sterile water by dissolving the 
dye in the incubator for 1-2 hours
Eggs were freshly washed with soap water and rinsed  for 30 minutes and were 
placed in sterile cover. Alternatively the eggs may be dried  by cleaning shell with 
methylated spirit and burning it.
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The eggs were beaten with sterile egg beater and there is no need to filter the 
beaten egg.
For complete medium the following were mixed
Mineral salt solution                                      600ml
Malachite green solution                              20ml
Beaten egg                                                     1000ml
The prepared media was distributed in 5 ml amount in sterile screwed tube or 
McCartney bottles and screw caps were tightly closed.
2. TWEEN HYDROLYSIS
Ingredients 
 80 M/15 phosphate buffer, Ph 7.
 Tween -80
 Neutral red solution , 0.1% gm of neutral red powder in 100 ml of distilled 
water.
0.5 ml of Tween-80 was mixed  with 100 ml of phosphate buffer .  
2ml neutral red solution was added to it.  2 ml amounts were 
distributed in screw-capped test tubes and sterilize at 15 lbs 
pressure for 15 minutes. The tubes should be amber coloured and 
were stored in the cold.
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3. UREA BROTH
Ingredients
Peptone                                1.0 gm
Dextrose                               1.0 gm
Sodium chloride                   5.0 gm
Potassium phosphate,
Monobasic                            0.4 gm
Urea                                       20 gm
Phenol red 1% solution       1ml
Tween 80                               0.1ml
Distilled water                     1000ml
The ingredients were dissolved in distilled water and the pH was adjusted to 5.8+/-
0.1.It was then sterilized by filtration. 1.5 ml of the broth was distributed in screw 
capped tubes. It was stored at 40C up to 2 months.
4. CATALASE REAGENTS
1.30% Hydrogen peroxide(commercially available as superoxol)
2.10% tween 80
3.M/15 phosphate buffer(0.067M)
5. NITRATE  TEST SUBSTRATE
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NaNO3            -                 0.8 gm
KH2PO4         -                  1.17 gm
Na2HPO4       -                  1.94 gm
H2O               -                  999 ml
The chemicals were  dissolved and mixed.pH was adjusted to 7.It was then 
autoclaved and 2 ml of it was  distributed in sterile tubes.
6. NIACIN TEST REAGENTS
1) 4% aniline solution
Aniline    4 gm
Ethanol 100 ml
Both were mixed in amber bottle and were stored in refrigerator in dark
2) Cyanogen bromide solution , approx. 10%
A saturated aqueous solution of cyanogen bromide of approx. 10% was prepared.It 
was then stored at 40C in the refrigerator.
Both the reagents must be freshly prepared.
7. ARYL SULFATASE TEST
Stock substrate;
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 2.6 gm of phenolphthalein disulphate tripotassium salt was dissolved in 50 
ml of sterile deionized water
 It was sterilized by membrane filtration (0.22um pore size)
 It was stored in the refrigerator at 2-80C
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